Tetrahedron Letters
Formal synthesis of 14-membered unsymmetrical bis-macrolactone,
(ꢀ)-colletodiol
Navnath B. Khomane a,b, Rayala Naveen Kumar a, Prakash R. Mali a,b, Prashishkumar K. Shirsat a,b
,
H.M. Meshram a,
⇑
a Medicinal Chemistry and Biotechnology Division, CSIR-Indian Institute of Chemical Technology, Hyderabad 500007, India
b Academy of Scientific and Innovative Research, New Delhi 110 025, India
a r t i c l e i n f o
a b s t r a c t
Article history:
Formal synthesis of 14-membered unsymmetrical bis-macrolactone, (ꢀ)-colletodiol was accomplished
from homopropargylic alcohol derivative. Building of the two different hydroxy acid fragments from
the same intermediate of homoallylic alcohol was particularly advantageous. A Sharpless asymmetric
dihydroxylation, homologation of carbon chain, a Pinnick oxidation, and a macrolactonization to assem-
ble the 14-membered macrodiolide were the additional salient features of this convergent synthesis.
Ó 2017 Elsevier Ltd. All rights reserved.
Received 1 October 2017
Revised 30 October 2017
Accepted 1 November 2017
Available online xxxx
Keywords:
Colletodiol
Macrolactonization
Sharpless dihydroxylation
Horner-Wadsworth-Emmons olefination
Pinnik oxidation
Introduction
and also significant activities against Bacillus subtilis, and the fungi
Trichophyton mentagrophytes.6 Colletodiol 4, itself known to inhibit
Naturally occurring 14 membered bis-lactones, which are iso-
lated from various fungi and marine sponges, are a family of sec-
ondary metabolites with prominent biological activity.1 The 14-
membered macrodiolide, colletodiol 4 is a heterodimer with two
different subunits. In 1966, initial colletodiol 4 was isolated from
a metabolic product of Colletotrichum capsici by J.F. Grove and his
co-workers.2 Seebach and Mitsunobu established the absolute,
and relative stereochemistry of colletodiol 4.3 In 1968 along with
colletodiol, MacMillan group isolated another three 14 membered
bis-lactone, colletol 2, colletoallol 1 and colletoketol 3 from plant
colletotricum capsici.4 While Ronald and Gurusiddhai isolated a
macrocyclic bis-lactone, Grahamimycine A1 (not shown) from
cytospora which exhibits potential antibiotic activity against many
pathogenic microorganism, blue green algae, and various species of
bacteria while colletodiol 4 possess mild antibiotic activity.5 Previ-
ous studies shown that the mechanism of action of this antibiotic
agent was differs from the known agents which indicated that this
was new class of antibiotic agent. 4-Keto-clonostachydiol 6 from
the same family of colletodiol, exhibits various biological proper-
the replication of influenza A virus WSN/H1N1 by reducing the
activity of viral RNA polymerase.7 These new class of macrodiolide
antibiotics in which bis-lactone ring is made up of two unsymmet-
rical subunits (Fig. 1). Due to their limited availability from biolog-
ical sources, these bis-macrolides have not been fully tested for
their biological activity. In many natural products, reversal of
stereochemistry at one centre or its enantiomer is more active than
8
natural isolated products.
Due to their promising biological activity and distinctive struc-
tural features, these metabolites became attractive synthetic tar-
gets for the synthetic chemists. However, synthetic approaches in
this area have not been entirely explored. There have been several
syntheses of colletol 2,9 grahamimycine A 3.10 But there are few
report for the synthesis of (+)-colletodiol 4.3,11 Synthesis of gra-
hamimycin A 3 was easily achieved from the selective oxidation
of hydroxyl group at C11 of colletodiol
4 in a single step
(Scheme 1).11f
As a part of our interest on the synthesis of antibiotic agent12 and
total synthesis of bioactive natural products.13 Herein we report the
stereoselective formal synthesis of unnatural (ꢀ)-colletodiol 5 by a
convergent synthetic strategy involving enantioselective prochiral
ketone reduction, Sharpless asymmetric dihydroxylation, and
intramolecular macrolactonization. Synthesis of other bioactive
ties, such as potent cytotoxicity against P388 cells (IC50 0.55 lM)
⇑
Corresponding author.
E-mail
addresses:
(H.M. Meshram).
0040-4039/Ó 2017 Elsevier Ltd. All rights reserved.